Why Did BioNTech Halt Its Colorectal Cancer Vaccine Trial? What It Means for mRNA Cancer Vaccines
by BioNTech’s decision to terminate its Phase 2 colorectal cancer vaccine trial is an important warning for the mRNA oncology industry: promising technology alone does not …